| Phase 12 trials |
|
Phase 1
|
NCT06625710 |
Oct 2024 → Aug 2025 |
neurodegenerative disease |
GemVax & Kael |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01342224 |
Jan 2011 → Jun 2012 |
pancreatic adenocarcinoma |
Providence Health & Services |
Completed
|
No outcome recorded
|
| Phase 1/21 trial |
|
Phase 1/2
|
NCT01247623 |
Jan 2005 → Sep 2011 |
melanoma |
Oslo University Hospital |
Completed
|
No outcome recorded
|
| Phase 27 trials |
|
Phase 2
|
NCT06235775 |
Dec 2023 → Sep 2025 |
progressive supranuclear palsy |
GemVax & Kael |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT05819658 |
Jun 2023 → Oct 2024 |
progressive supranuclear palsy |
GemVax & Kael |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT05189210 |
Oct 2022 → Apr 2025 |
— |
GemVax & Kael |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT03959553 |
Sep 2019 → Aug 2021 |
Alzheimer disease |
GemVax & Kael |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT03184467 |
Sep 2017 → Sep 2019 |
Alzheimer disease |
GemVax & Kael |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT02855892 |
Oct 2015 → Oct 2016 |
benign prostatic hyperplasia |
GemVax & Kael |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00444782 |
Nov 2006 → Apr 2008 |
hepatocellular carcinoma |
Pharmexa A/S |
Completed
|
No outcome recorded
|
| Phase 35 trials |
|
Phase 3
|
NCT05303701 |
Jul 2027 → Jan 2028 expected |
Alzheimer disease |
Samsung Pharmaceutical Co., Ltd. |
Not yet recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT02854072 |
Nov 2015 → May 2018 |
malignant pancreatic neoplasm |
Samsung Pharmaceutical Co., Ltd. |
Unknown
|
No outcome recorded
|
|
Phase 3
|
NCT01579188 |
May 2012 → May 2016 |
non-small cell lung carcinoma |
Kael-GemVax Co., Ltd. |
Unknown
|
No outcome recorded
|
|
Phase 3
|
NCT00425360 |
Sep 2006 → Mar 2013 |
malignant pancreatic neoplasm |
Royal Liverpool University Hospital |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00358566 |
Jun 2006 → Aug 2008 |
malignant pancreatic neoplasm |
Pharmexa A/S |
Terminated
|
No outcome recorded
|
| Phase not applicable1 trial |
| — |
NCT00509457 |
Nov 2006 → Aug 2009 |
non-small cell lung carcinoma |
Oslo University Hospital |
Completed
|
No outcome recorded
|